References
- McGuireHLongsonDAdlerAFarmerALewinIGuideline Development GroupManagement of type 2 diabetes in adults: summary of updated NICE guidanceBMJ2016353i157527052837
- InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care201538114014925538310
- International Diabetes Federation Guideline Development GroupGlobal guideline for type 2 diabetesDiabetes Res Clin Pract2014104115224508150
- Diabetesforeningen [webpage on the Internet]The National Danish Diabetes Registry2016 Available from: http://www.diabetes.dk/presse/diabetes-i-tal/det-nationale-diabetesregister.aspxAccessed March 20, 2016
- SchmidtMPedersenLSorensenHTThe Danish Civil Registration System as a tool in epidemiologyEur J Epidemiol201429854154924965263
- Danish Serum Institute [webpage on the Internet]Statistics on annual sales of medicines in Denmark based on the data from the Register of Medicinal Products Statistics2016 Available from: www.medstat.dk/enAccessed January 19, 2016
- KildemoesHWSorensenHTHallasJThe Danish National Prescription RegistryScand J Public Health2011397 suppl384121775349
- JohannesdottirSAHorvath-PuhoEEhrensteinVSchmidtMPedersenLSorensenHTExisting data sources for clinical epidemiology: the Danish national database of reimbursed prescriptionsClin Epidemiol2012430331323204870
- EhrensteinVAntonsenSPedersenLExisting data sources for clinical epidemiology: Aarhus University Prescription DatabaseClin Epidemiol2010227327921152254
- SharmaMNazarethIPetersenITrends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort studyBMJ Open201661e010210
- TorreCGuerreiroJde Oliveira MartinsSRaposoJFMartinsAPLeufkensHPatterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over timePrim Care Diabetes20159648248925911273
- ThomsenRWBaggesenLMSvenssonEEarly glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort studyDiabetes Obes Metab201517877178025929277
- HamppCBorders-HemphillVMoenyDGWysowskiDKUse of antidiabetic drugs in the U.S., 2003–2012Diabetes Care20143751367137424623020
- KohroTYamazakiTSatoHTrends in antidiabetic prescription patterns in Japan from 2005 to 2011Int Heart J2013542939723676369
- European Medicine Agency [webpage on the Internet]European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid=WC0b01ac058004d5c1Accessed January 10, 2016
- EhrensteinVHernandezRKUlrichsenSPRosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010BMJ Open201339e003424
- ThomsenRWSorensenHTUsing registries to identify type 2 diabetes patientsClin Epidemiol201471325565888
- ThomsenRWBaggesenLMSogaardMEffectiveness of intensification therapies in Danes with type 2 diabetes who use basal insulin: a population-based studyDiabet Med Epub201669